Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo (Q39350899)

11 September 2017

Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo (English)

1 reference

11 September 2017

hepatocellular carcinoma

1 reference

Weilin Wang

1

1 reference

11 September 2017

Pengfei Huang

2

1 reference

11 September 2017

Lufei Zhang

3

1 reference

11 September 2017

Jianfeng Wei

4

1 reference

11 September 2017

Qingsong Xie

5

1 reference

11 September 2017

Qiang Sun

6

1 reference

11 September 2017

Xiaohu Zhou

7

1 reference

11 September 2017

Haiyang Xie

8

1 reference

11 September 2017

Lin Zhou

9

1 reference

11 September 2017

Shusen Zheng

10

1 reference

11 September 2017

14 October 2013

1 reference

11 September 2017

1 reference

11 September 2017

104

1 reference

11 September 2017

11

1 reference

11 September 2017

1523-1531

1 reference

Global cancer statistics, 2002

11 September 2017

1 reference

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Interventional radiological treatment of hepatocellular carcinoma: an update

21 January 2018

1 reference

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

21 January 2018

1 reference

Gene therapy of liver cancer

21 January 2018

1 reference

Gene- and immunotherapy for hepatocellular carcinoma

21 January 2018

1 reference

The multifaceted roles of chemokines in malignancy

21 January 2018

1 reference

Cancer CXC chemokine networks and tumour angiogenesis

21 January 2018

1 reference

Chemokines in tumor angiogenesis and metastasis

21 January 2018

1 reference

In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue

21 January 2018

1 reference

Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells

21 January 2018

1 reference

Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells

21 January 2018

1 reference

BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells

21 January 2018

1 reference

Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo

21 January 2018

1 reference

B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine

21 January 2018

1 reference

Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine

21 January 2018

1 reference

Expression of CXCL14 and its anticancer role in breast cancer

21 January 2018

1 reference

Modulation of CXCL14 (BRAK) expression in prostate cancer

21 January 2018

1 reference

CXCL14 expression and potential function in pancreatic cancer

21 January 2018

1 reference

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

21 January 2018

1 reference

An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population.

21 January 2018

1 reference

CpG methylation, chromatin structure and gene silencing-a three-way connection

21 January 2018

1 reference

Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism

21 January 2018

1 reference

Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells

21 January 2018

1 reference

Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.

21 January 2018

1 reference

Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase

21 January 2018

1 reference

Phosphorylation and activation of 13S condensin by Cdc2 in vitro

21 January 2018

1 reference

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

21 January 2018

1 reference

Lymphocyte traffic control by chemokines

21 January 2018

1 reference

Role of tumor associated fibroblasts in human liver regeneration, cirrhosis, and cancer

21 January 2018

1 reference

In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24033560

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Proton therapy for hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24033560

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumour-immune cell interactions modulated by chemokines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24033560

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/CAS.12279

1 reference

11 September 2017

0 references

1 reference